TDC
MBII

Thompson Davis & Co’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Thompson Davis & Co’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$18K Buy
+10,000
New +$19.4K 0.04% 364

Other funds holding MBII

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IAM
ICM Asset Management Spokane, Washington $18.1M AUM 30.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Thompson Davis & Co's MBII Position: Q3 2018 in Review

Thompson Davis & Co opened a new position in Marrone Bio Innovations, Inc. (MBII) in Q3 2018: 10,000 shares worth $18K. The stake represents 0.04% of the portfolio and ranks #364 among its holdings.

45 funds tracked by Wall St. Rank hold MBII as of Q3 2018.

  • Thompson Davis & Co held 10,000 shares of Marrone Bio Innovations, Inc. worth $18K as of Q3 2018.
  • Marrone Bio Innovations, Inc. was a new Thompson Davis & Co position in Q3 2018.
  • Marrone Bio Innovations, Inc. made up 0.04% of Thompson Davis & Co's portfolio in Q3 2018, its #364 holding.
  • 45 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.